Personal information

Emails & domains

Verified email domains

Websites & social links

Erasmus MC profile

Other IDs

ResearcherID: L-2264-2015

Keywords

Virology, Immunology, T-cells, Measles, SARS-CoV-2

Countries

Netherlands

Activities

Collapse all

Employment (2)

Erasmus MC: Rotterdam, NL

2008-10-01 to present | PI / Assistant Professor (Viroscience)
Employment
Source: Self-asserted source
de Vries, RD

La Jolla Institute for Immunology: La Jolla, CA, US

2020-01-01 to 2020-04-01 | Visiting Scientist
Employment
Source: Self-asserted source
de Vries, RD

Education and qualifications (2)

Erasmus MC: Rotterdam, NL

2008 to 2013 | PhD (Viroscience)
Education
Source: Self-asserted source
de Vries, RD

Leids Universitair Medisch Centrum: Leiden, Zuid-Holland, NL

2000 to 2005 | MSc
Education
Source: Self-asserted source
de Vries, RD

Professional activities (8)

Microbiology Society: London, GB

Membership
Source: Self-asserted source
de Vries, RD

Dutch Society Immunology: Amsterdam, NL

2021 to present
Membership
Source: Self-asserted source
de Vries, RD

European Society for Paediatric Infectious Diseases: Bathgate, GB

2020 to present
Membership
Source: Self-asserted source
de Vries, RD

American Society for Virology: Minnesota, US

2019 to present
Membership
Source: Self-asserted source
de Vries, RD

European Society for Virology: Goteborg, SE

2018 to present
Service
Source: Self-asserted source
de Vries, RD

European Society of Clinical Microbiology and Infectious Diseases: Geneva, CH

2016 to present
Service
Source: Self-asserted source
de Vries, RD

Hogeschool van Arnhem en Nijmegen: Arnhem, Gelderland, NL

2015 to present | Guest teacher
Invited position
Source: Self-asserted source
de Vries, RD

Royal Netherlands Academy of Arts and Sciences: Amsterdam, NL

2019 | Beijerinck Premium
Distinction
Source: Self-asserted source
de Vries, RD

Funding (7)

Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2

2021 to 2026 | Grant
National Institutes of Health (Md., Md., US)
Part of GRANT_NUMBER:

R01AI160961
Source: Self-asserted source
de Vries, RD

Fusion inhibitors that block host-to-host transmission of SARS-CoV-2

2021 to 2026 | Grant
National Institutes of Health (Md., Md., US)
Part of GRANT_NUMBER:

R01AI160953
Source: Self-asserted source
de Vries, RD

Novel tools to support measles control and elimination

2021 to 2024 | Grant
ZonMw (Amsterdam, NL)
Part of GRANT_NUMBER:

10150511910052
Source: Self-asserted source
de Vries, RD

CoviCross: Detection of specific and cross-reactive cellular responses to coronaviruses: towards a diagnostic T-cell assay for COVID-19

2021 to 2023 | Grant
Health~Holland (Amsterdam, NL)
GRANT_NUMBER:

EMCLSH20017
Source: Self-asserted source
de Vries, RD

RECOVAC: REnal patients COVID-19 VAccination consortium

2021 to 2022 | Grant
ZonMw (Amsterdam, NL)
Source: Self-asserted source
de Vries, RD

Switching of COVID-19 vaccines: A solution for the problems?

2021 to 2022 | Grant
ZonMw (Amsterdam, NL)
GRANT_NUMBER:

10430072110001
Source: Self-asserted source
de Vries, RD

VACOPID: Vaccination Against Covid in Primary Immune Deficiencies

Grant
ZonMw (Amsterdam, NL)
GRANT_NUMBER:

10430072010006
Source: Self-asserted source
de Vries, RD

Works (50 of 91)

Items per page:
Page 1 of 2

The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic

Pathogens
2023-06 | Journal article | Author
DOI: 10.3390/pathogens12070862
Contributors: Linda Petrone; Alessandro Sette; de Vries, RD; Delia Goletti
Source: check_circle
Multidisciplinary Digital Publishing Institute

Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2022-07-07 | Journal article
DOI: 10.1093/cid/ciac557
PMID: 35796536
Source: Self-asserted source
de Vries, RD

Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters.

Emerging microbes & infections
2022-07-05 | Journal article
DOI: 10.1080/22221751.2022.2095932
PMID: 35787236
Source: Self-asserted source
de Vries, RD

Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct.

Science immunology
2022-06-23 | Journal article
DOI: 10.1126/sciimmunol.abq4450
PMID: 35737747
Source: Self-asserted source
de Vries, RD

Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2022-06-20 | Journal article
DOI: 10.1093/cid/ciac495
PMID: 35723273
Source: Self-asserted source
de Vries, RD

Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern.

mBio
2022-06-13 | Journal article
DOI: 10.1128/mbio.01249-22
PMID: 35695453
PMC: PMC9239157
Source: Self-asserted source
de Vries, RD

Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds

Viruses
2022-05 | Journal article | Author
DOI: 10.3390/v14061186
Contributors: Katharina S. Schmitz; Mona V. Lange; Lennert Gommers; Kim Handrejk; Danielle P. Porter; Christopher Alabi; Anne Moscona; Matteo Porotto; de Vries, RD; Rik L. de Swart
Source: check_circle
Multidisciplinary Digital Publishing Institute

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.

The Journal of allergy and clinical immunology
2022-04-11 | Journal article
DOI: 10.1016/j.jaci.2022.04.002
PMID: 35421449
PMC: PMC8996444
Source: Self-asserted source
de Vries, RD

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Transplantation
2022-04-01 | Journal article
DOI: 10.1097/tp.0000000000003983
PMID: 34753894
PMC: PMC8942603
Source: Self-asserted source
de Vries, RD

Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients.

Science immunology
2022-03-25 | Journal article
DOI: 10.1126/sciimmunol.abo2202
PMID: 35113647
PMC: PMC8939771
Source: Self-asserted source
de Vries, RD

High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2022-03-16 | Journal article
DOI: 10.1016/j.healun.2022.03.006
PMID: 35606065
PMC: PMC8924026
Source: Self-asserted source
de Vries, RD

Modeling Infection and Tropism of Human Parainfluenza Virus Type 3 in Ferrets.

mBio
2022-02-15 | Journal article
DOI: 10.1128/mbio.03831-21
PMID: 35164568
PMC: PMC8844927
Source: Self-asserted source
de Vries, RD

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.

The New England journal of medicine
2022-01-19 | Journal article
DOI: 10.1056/nejmoa2116747
PMID: 35045226
PMC: PMC8796791
Source: Self-asserted source
de Vries, RD

Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model.

Thrombosis research
2021-12-21 | Journal article
DOI: 10.1016/j.thromres.2021.12.015
PMID: 34954402
PMC: PMC8690567
Source: Self-asserted source
de Vries, RD

Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions.

The Journal of clinical investigation
2021-12-01 | Journal article
DOI: 10.1172/jci155499
PMID: 34907916
Source: Self-asserted source
de Vries, RD

Understanding the association between sleep, shift work and COVID-19 vaccine immune response efficacy: Protocol of the S-CORE study.

Journal of sleep research
2021-10-06 | Journal article
DOI: 10.1111/jsr.13496
PMID: 34617358
Source: Self-asserted source
de Vries, RD

Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol.

Frontiers in immunology
2021-09-24 | Journal article
DOI: 10.3389/fimmu.2021.753319
PMID: 34691071
PMC: PMC8529966
Source: Self-asserted source
de Vries, RD

Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes <i>In Vitro</i> and <i>In Vivo</i>.

mSphere
2021-09-22 | Journal article
DOI: 10.1128/msphere.00537-21
PMID: 34550005
Source: Self-asserted source
de Vries, RD

Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients.

The Journal of clinical investigation
2021-09-07 | Journal article
DOI: 10.1172/jci150613
PMID: 34499051
Source: Self-asserted source
de Vries, RD

Comparable Infection Level and Tropism of Measles Virus and Canine Distemper Virus in Organotypic Brain Slice Cultures Obtained from Natural Host Species

Viruses
2021-08 | Journal article | Author
DOI: 10.3390/v13081582
Contributors: Brigitta M. Laksono; Diana N. Tran; Ivanela Kondova; Harry G. H. van Engelen; Samira Michels; Sham Nambulli; de Vries, RD; W. Paul Duprex; Verjans G.M.G.M.; Rik L. de Swart
Source: check_circle
Multidisciplinary Digital Publishing Institute

Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test.

One health (Amsterdam, Netherlands)
2021-08-21 | Journal article
DOI: 10.1016/j.onehlt.2021.100313
PMID: 34458548
PMC: PMC8378998
Source: Self-asserted source
de Vries, RD
grade
Preferred source (of 2)‎

<i>In Vitro</i> Modelling of Respiratory Virus Infections in Human Airway Epithelial Cells - A Systematic Review.

Frontiers in immunology
2021-08-18 | Journal article
DOI: 10.3389/fimmu.2021.683002
PMID: 34489934
PMC: PMC8418200
Source: Self-asserted source
de Vries, RD

Animal models of SARS-CoV-2 transmission.

Current opinion in virology
2021-06-29 | Journal article
DOI: 10.1016/j.coviro.2021.06.007
PMID: 34256352
PMC: PMC8238653
Source: Self-asserted source
de Vries, RD

SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.

The Journal of infectious diseases
2021-06-01 | Journal article
DOI: 10.1093/infdis/jiab289
PMID: 34043806
PMC: PMC8243397
Source: Self-asserted source
de Vries, RD

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC)

Nephrology Dialysis Transplantation
2021-05-26 | Journal article
DOI: 10.1093/ndt/gfab186
PMID: 34038554
Source: Self-asserted source
de Vries, RD
grade
Preferred source (of 2)‎

Human Respiratory Syncytial Virus Subgroup A and B Infections in Nasal, Bronchial, Small-Airway, and Organoid-Derived Respiratory Cultures.

mSphere
2021-05-12 | Journal article
DOI: 10.1128/msphere.00237-21
PMID: 33980679
PMC: PMC8125053
Source: Self-asserted source
de Vries, RD

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.

Science immunology
2021-05-01 | Journal article
DOI: 10.1126/sciimmunol.abj1750
PMID: 34035118
Source: Self-asserted source
de Vries, RD

Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets.

Science (New York, N.Y.)
2021-02 | Journal article
DOI: 10.1126/science.abf4896
PMID: 33597220
Contributors: de Vries RD; Schmitz KS; Bovier FT; Predella C; Khao J; Noack D; Haagmans BL; Herfst S; Stearns KN; Drew-Bear J et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central
grade
Preferred source (of 3)‎

Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition.

Frontiers in immunology
2021-02-04 | Journal article
DOI: 10.3389/fimmu.2021.627186
PMID: 33613575
PMC: PMC7889602
Source: Self-asserted source
de Vries, RD

Alveolar barrier disruption in varicella pneumonia is associated with neutrophil extracellular trap formation.

JCI insight
2020-11 | Journal article
DOI: 10.1172/jci.insight.138900
PMID: 33021967
PMC: PMC7710321
Contributors: Ouwendijk WJ; van den Ham HJ; Delany MW; van Kampen JJ; van Nierop GP; Mehraban T; Zaaraoui-Boutahar F; van IJcken WF; van den Brand JM; de Vries RD et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Measles skin rash: Infection of lymphoid and myeloid cells in the dermis precedes viral dissemination to the epidermis.

PLoS pathogens
2020-10 | Journal article
DOI: 10.1371/journal.ppat.1008253
PMID: 33031460
PMC: PMC7575069
Contributors: Laksono BM; Fortugno P; Nijmeijer BM; de Vries RD; Cordisco S; Kuiken T; Geijtenbeek TBH; Duprex WP; Brancati F; de Swart RL
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity.

Signal transduction and targeted therapy
2020-10 | Journal article
DOI: 10.1038/s41392-020-00338-w
PMID: 33024093
PMC: PMC7537775
Contributors: de Vries RD
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

2020-08 | Preprint
DOI: 10.1101/2020.08.24.264630
OTHER-ID:

PPR205471
Contributors: Haagmans BL; Noack D; Okba NM; Li W; Wang C; Bestebroer T; de Vries R; Herfst S; de Meulder D; van Run P et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Human Paramyxovirus Infections Induce T Cells That Cross-React with Zoonotic Henipaviruses.

mBio
2020-07 | Journal article
DOI: 10.1128/mbio.00972-20
PMID: 32636246
PMC: PMC7343989
Contributors: de Vries RD; de Jong A; Verburgh RJ; Sauerhering L; van Nierop GP; van Binnendijk RS; Osterhaus ADME; Maisner A; Koopmans MPG; de Swart RL
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Identification and characterization of CD4+ T cell epitopes after Shingrix vaccination

2020-07 | Other
DOI: 10.1101/2020.07.29.227082
OTHER-ID:

PPR193933
Contributors: Voic H; de Vries RD; Sidney J; Rubiro P; Moore E; Phillips E; Mallal S; Schwan B; Weiskopf D; Sette A et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central
grade
Preferred source (of 3)‎

In vivo comparison of a laboratory-adapted and clinical-isolate-based recombinant human respiratory syncytial virus.

The Journal of general virology
2020-07 | Journal article
DOI: 10.1099/jgv.0.001468
PMID: 32692644
Contributors: Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.

Science immunology
2020-06 | Journal article
DOI: 10.1126/sciimmunol.abd2071
PMID: 32591408
PMC: PMC7319493
Contributors: Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Measles pathogenesis, immune suppression and animal models.

Current opinion in virology
2020-04 | Journal article
DOI: 10.1016/j.coviro.2020.03.002
PMID: 32339942
Contributors: Laksono BM; de Vries RD; Duprex WP; de Swart RL
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome

2020-04 | Other
DOI: 10.1101/2020.04.11.20062349
OTHER-ID:

PPR152420
Contributors: Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NM; Endeman H; van den Akker JP; Molenkamp R; Koopmans MP; van Gorp EC et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

mSphere of Influence: Understanding Virus-Host Interactions Requires a Multifaceted Approach.

mSphere
2020-03 | Journal article
DOI: 10.1128/msphere.00105-20
PMID: 32213621
PMC: PMC7096622
Contributors: de Vries RD
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.

Virus research
2019-12 | Journal article
DOI: 10.1016/j.virusres.2019.197839
PMID: 31837382
Contributors: de Vries RD; Nieuwkoop NJ; Krammer F; Hu B; Rimmelzwaan GF
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Measles skin rash: infection of lymphoid and myeloid cells in the dermis precedes viral dissemination to keratinocytes in the epidermis

2019-12 | Other
DOI: 10.1101/867531
OTHER-ID:

PPR104794
Contributors: Laksono BM; Fortugno P; Nijmeijer BM; de Vries RD; Cordisco S; van Nieuwkoop S; Kuiken T; Geijtenbeek TBH; Duprex WP; Brancati F et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles.

Science immunology
2019-11 | Journal article
DOI: 10.1126/sciimmunol.aay6125
PMID: 31672862
Contributors: Petrova VN; Sawatsky B; Han AX; Laksono BM; Walz L; Parker E; Pieper K; Anderson CA; de Vries RD; Lanzavecchia A et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens.

Science (New York, N.Y.)
2019-11 | Journal article
DOI: 10.1126/science.aay6485
PMID: 31672891
Contributors: Mina MJ; Kula T; Leng Y; Li M; de Vries RD; Knip M; Siljander H; Rewers M; Choy DF; Wilson MS et al.
Source: Self-asserted source
de Vries, RD via Europe PubMed Central

Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines

Scientific Reports
2018 | Journal article
DOI: 10.1038/S41598-018-24820-2
WOSUID: WOS:000430662500003
Contributors: Carolien E. van de Sandt; Erwin de Bruin; Rory D. de Vries; Dennis de Meulder; Arwen F. Altenburg; Guus F. Rimmelzwaan; Marion P. G. Koopmans; Ron A. M. Fouchier; Fiona R. M. van der Klis; Stella E. van Trierum
Source: check_circle
Web of Science Researcher Profile Sync

In Vitro Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B Cells

Journal of Virology
2018 | Journal article
DOI: 10.1128/JVI.00131-18
WOSUID: WOS:000428538800004
Contributors: Menno C. van Zelm; Peter D. Katsikis; Jacques J. M. van Dongen; van Dongen JJM; Brem MD; Brigitta M. Laksono; van Zelm MC; de Swart RL; Maarten D. Brem; Koopmans MPG et al.
Source: check_circle
Web of Science Researcher Profile Sync

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

The Journal of Infectious Diseases
2018 | Journal article
DOI: 10.1093/INFDIS/JIY214
WOSUID: WOS:000439176000016
Contributors: Guus F Rimmelzwaan; Albert D M E Osterhaus; Marion P G Koopmans; Nella J Nieuwkoop; Rory D de Vries; Gerd Sutter; Ron A M Fouchier; Arwen F Altenburg; Joost H C M Kreijtz; David F Nieuwenhuijse et al.
Source: check_circle
Web of Science Researcher Profile Sync

Matrix-M (TM) adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

Immunologic Research
2018 | Journal article
DOI: 10.1007/S12026-018-8991-X
WOSUID: WOS:000430051600002
Contributors: Linda Stertman; Guus F. Rimmelzwaan; Rory D. de Vries; Fons Bosman; Karin Lövgren Bengtsson; Arwen F. Altenburg; Sofia E. Magnusson
Source: check_circle
Web of Science Researcher Profile Sync

Modeling the measles paradox reveals the importance of cellular immunity in regulating viral clearance

PLOS Pathogens
2018 | Journal article
DOI: 10.1371/JOURNAL.PPAT.1007493
WOSUID: WOS:000454721500034
Contributors: Bryan T. Grenfell; Diane E. Griffin; Roger D. Kouyos; Wen-Hsuan W. Lin; Ashley N. Nelson; Michael J. Mina; Rory D. de Vries; Rik L. de Swart; Andrew J. Yates; Sinead E. Morris
Source: check_circle
Web of Science Researcher Profile Sync

Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity

The Journal of Infectious Diseases
2018 | Journal article
DOI: 10.1093/INFDIS/JIX546
WOSUID: WOS:000419612200002
Contributors: Guus F Rimmelzwaan; Marion P G Koopmans; Fiona R M van der Klis; Nella J Nieuwkoop; Rory D de Vries; Florian Krammer
Source: check_circle
Web of Science Researcher Profile Sync
Items per page:
Page 1 of 2

Peer review (137 reviews for 42 publications/grants)

Review activity for Advances in virology. (1)
Review activity for BMC microbiology (1)
Review activity for Cell reports. (1)
Review activity for Cellular & molecular immunology (2)
Review activity for Clinical infectious diseases. (3)
Review activity for Current opinion in virology. (6)
Review activity for EBioMedicine. (2)
Review activity for EClinicalMedicine. (2)
Review activity for Emerging infectious diseases. (2)
Review activity for Emerging microbes & infections. (1)
Review activity for Euro surveillance. (1)
Review activity for Expert review of vaccines (1)
Review activity for Frontiers in cellular and infection microbiology. (1)
Review activity for Future microbiology. (1)
Review activity for International journal of infectious diseases. (1)
Review activity for iScience. (5)
Review activity for Journal of infectious diseases. (9)
Review activity for Journal of virology : (1)
Review activity for MBio. (1)
Review activity for Microbiology spectrum. (3)
Review activity for Molecular therapy (1)
Review activity for Nature (1)
Review activity for Nature communications (17)
Review activity for Nature medicine. (4)
Review activity for Nature microbiology. (1)
Review activity for Nephrology, dialysis, transplantation. (2)
Review activity for npj vaccines. (2)
Review activity for Pathogens and disease / (1)
Review activity for PloS one. (1)
Review activity for PLOS pathogens : (1)
Review activity for Proceedings of the National Academy of Sciences of the United States of America. (3)
Review activity for Science immunology. (12)
Review activity for Science translational medicine. (5)
Review activity for Science. (1)
Review activity for Spectrum : (1)
Review activity for The Lancet microbe. (4)
Review activity for The lancet. (8)
Review activity for The Lancet. (14)
Review activity for Vaccine (4)
Review activity for Vaccines. (3)
Review activity for Virus research. (1)
Review activity for Viruses. (5)
How many people are using ORCID?